Actively Recruiting
Changes in Muscle Mass, Strength, and Muscle Protein Synthesis in Response to 5 Days of Bedrest in Young, Healthy Adults
Led by Queen's University · Updated on 2025-09-22
12
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
Q
Queen's University
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying how five days of strict bedrest affect muscle mass, strength, and metabolic function in healthy young adults aged 18 to 30. The study aims to understand how skeletal muscle volume, strength, fatigue resistance, whole-body insulin sensitivity, mitochondrial function, and muscle protein synthesis change during this short-term disuse. This research addresses gaps in current knowledge about muscle loss and metabolic changes during clinically relevant bedrest periods. Participants will follow a 19-day study schedule, starting with baseline testing, then five days of their usual activities, followed by five days of strict bedrest where participants remain mostly horizontal but can sit up in bed and use a wheelchair for bathing and bathroom needs. Their diet and physical activity are controlled and monitored throughout. Tests include magnetic resonance imaging of thigh muscles, strength and power assessments, mixed meal tolerance tests, muscle biopsies, and blood sampling. During the study, participants will undergo repeated measurements of muscle volume, strength, fatigue, protein synthesis rates, insulin sensitivity, glucose metabolism, mitochondrial function, and muscle structure. These assessments happen before, during, and after the bedrest and control periods. The study also includes functional tests like the supine to stand test. The total involvement spans about 19 days, with careful monitoring of diet, activity, and health markers to track changes caused by bedrest.
CONDITIONS
Brief Title
Human Skeletal Muscle Response to 5 Days of Bedrest in Young Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females aged 18 to 30 years
- Body mass index (BMI) between 18.5 and 28 kg/m2
- Weight stable within plus or minus 2 kg for the past 6 months
- Generally healthy as confirmed by medical and physical activity questionnaires
- Recreationally active individuals
You will not qualify if you...
- BMI less than 18.5 or greater than 28 kg/m2
- Use of insulin to control blood glucose levels
- History of cardiovascular, respiratory, metabolic, neuromuscular, or bone-wasting diseases
- Use of medications affecting muscle protein turnover such as androgen or anabolic hormone therapy or chemotherapy
- Family history or personal history of thrombosis, platelet or coagulation disorders, or use of anticoagulant or antiplatelet medications
- Presence of unremoved or partially removed metal under the skin
- History of head or eye injury involving metal fragments
- Having implanted electrical devices such as pacemakers or neurostimulators
- Having implanted metal objects from surgery such as artificial joints, clips, or staples
- Pregnancy or possible pregnancy
- Wearing metal braces on teeth
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 5 days
Participants undergo a 5-day period of free-living with habitual daily activities to establish baseline measurements.
Assessments occur during this period but no specific visit cadence is provided
Duration - 5 days
Participants complete 5 days of strict bedrest, allowing only sitting up in bed and using a wheelchair for bathing or bathroom activities. Diet is controlled and physical activity is monitored.
Daily monitoring during bedrest period
Duration - Up to 1 day after bedrest
Participants undergo assessments to measure changes in muscle mass, strength, protein synthesis, and metabolic function after bedrest.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Queen's Univeristy
Kingston, Ontario, Canada, K7L 3N6
Actively Recruiting
Research Team
C
Chris McGlory, PhD.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here